Skip to content

Effectiveness Of Osteopathic Manipulative Treatment In NICU: A Multicenter Clinical Trial

Effectiveness Of Osteopathic Manipulative Treatment In Neonatal Intensive Care Units: A Multicenter Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01645137
Enrollment
690
Registered
2012-07-20
Start date
2012-07-31
Completion date
2013-10-31
Last updated
2014-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity

Keywords

prematurity, OMT, complementary and alternative medicine, neonates, length of stay

Brief summary

The use of complementary and alternative medicine in neonatal ward has been steadily rising during the last decade. This integrated medicine approach has been shown to be helpful to improve neonatal health care. Osteopathic manipulative treatment (OMT) has been applied to premature infants to reduce the length of stay and to cope with clinical complications. Results from previous studies documented the positive association between OMT and shorter period of hospitalisation as well as improvement of clinical conditions. The aim of this nationwide multicenter study is to demonstrate the effect of OMT on length of stay (LOS) in premature infants across 3 neonatal intensive care units (NICU).

Interventions

OTHERosteopathic manipulative treatment

Patients from this group received osteopathic treatments twice a week for the entire length of stay in the unit.

OTHERUsual care

Patients from control group received standard care plus osteopathic evaluation only, according to the same schedule as the study group.

Sponsors

Italian Academy of Traditional Osteopathy - AIOT
CollaboratorOTHER
European Institute for Evidence Based Osteopathic Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
29 Weeks to 37 Weeks
Healthy volunteers
Yes

Inclusion criteria

* preterm infants born at age between 29 and 37 weeks * osteopathic treatment performed \< 14 days after birth * preterms born in the same hospital

Exclusion criteria

* Gestational age \< 29 weeks * Gestational age \> 37 weeks * First OMT performed after 14 days from birth * genetic disorders * congenital disorders * cardiovascular abnormalities * proven or suspected necrotized enterocolitis with or without gastrointestinal perforation * proven or suspected abdominal obstruction * pre/post surgery patients * pneumoperitoneum * atelectasis * Newborn from an HIV seropositive/drug addicted mother * respiratory disorders * transferred to/from other hospital * admitted for preterminal comfort care (defined as neither intubation nor cardio-respiratory resuscitation)

Design outcomes

Primary

MeasureTime frame
Number of days of LOSparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks

Secondary

MeasureTime frame
number of episodes of vomitparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks
days to full enteral feedingparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks
pre-post difference in weight gainparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks
number of episodes of regurgitationparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks
number of episodes of stoolingparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks
NICU costsparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026